解剖学报 ›› 2021, Vol. 52 ›› Issue (5): 698-705.doi: 10.16098/j.issn.0529-1356.2021.05.005

• 神经生物学 • 上一篇    下一篇

DEAD-box RNA解旋酶5和转录因子12与肌萎缩侧索硬化症的关系

林宝勇1,2 徐进超1,2 应涵韬1,2 蒋欣2 刘焕彩2 王箐2* 王巧真2 陈燕春2,3*
  

  1. 1.潍坊医学院生命科学与技术学院生物技术专业; 2.神经疾病与再生修复重点实验室; 3.基础医学院组织学胚胎学教研室,山东 潍坊 261053
  • 收稿日期:2020-08-18 修回日期:2020-10-07 出版日期:2021-10-06 发布日期:2021-10-06
  • 通讯作者: 王箐;陈燕春 E-mail:cyc7907@163.com
  • 基金资助:
    山东省高校科技发展项目重点项目;山东省高等学校青创科技支持计划;国家级大学生创新训练项目;校级大学生创新基金

Relationship between DEAD-box helicase 5, transcription factor 12 and amyotrophic lateral sclerosis#br#

LIN Bao-yong1,2 XU Jin-chao1,2 YING Han-tao1,2 JIANG Xin2 LIU Huan-cai2 WANG Qing2* WANG Qiao-zhen2 CHEN Yan-chun2,3*#br#   

  1. 1.Biotechnology Specialty, School of Life Science and Technology; 2.Key Laboratory of Neurological Diseases and Regenerative Repair; 3.Department of Histology and Embryology, Basic Medical College, Weifang Medical University, Shandong Weifang 261053,China
  • Received:2020-08-18 Revised:2020-10-07 Online:2021-10-06 Published:2021-10-06
  • Contact: WANG Qing;CHEN Yan-chun E-mail:cyc7907@163.com

摘要:

目的  通过检测DEAD-box RNA解旋酶5(DDX5)和转录因子12(TCF12)在SOD1-G93A突变型肌萎缩侧索硬化症(ALS)转基因小鼠海马中表达情况及其相互作用关系,揭示DDX5和TCF12表达改变与ALS海马病变的关系。   方法  将42对SOD1-G93A突变型ALS转基因小鼠和野生型小鼠,按照95 d龄(发病早期)、108 d龄(发病中期)和122 d龄(发病晚期)分为3组,通过RT-PCR、Western blotting和免疫荧光双标记技术,检测DDX5和TCF12在海马中的表达情况,通过免疫共沉淀技术检测DDX5和TCF12蛋白之间是否具有相互作用。   结果  与同龄野生型小鼠相比,在SOD1-G93A突变型ALS转基因小鼠海马中DDX5和TCF12 mRNA无明显变化,而蛋白在 95 d、108 d和122 d表达均上调,差异均有统计学意义。海马齿状回和海马本部均可见DDX5和TCF12阳性细胞,且DDX5和TCF12在海马神经元中表达。SOD1-G93A突变型ALS转基因小鼠海马中DDX5和TCF12免疫阳性反应均较同龄野生型小鼠增强。免疫共沉淀实验检测发现,DDX5 和TCF12蛋白质之间存在相互作用。   结论  DDX5和TCF12蛋白在SOD1-G93A突变型ALS转基因小鼠海马组织中表达上调,DDX5和TCF12表达异常与ALS海马组织病变有关。

关键词: 肌萎缩侧索硬化症, DEAD-box解旋酶5, 转录因子12, 海马, 免疫共沉淀技术, SOD1-G93A转基因小鼠

Abstract:

Objective  To explore the relationship between the expression of DEAO-box helicase 5(DDX5) and transcription factor 12(TCF12) with amyotrophic lateral sclerosis(ALS) hippocampal lesions by detecting the expressions and the interaction of DDX5 and TCF12 in the hippocampus of SOD1-G93A mutant ALS transgenic mice.    Methods  Forty-two pairs of SOD1-G93A mutant ALS transgenic mice and wild-type mice were divided into three groups at the age of 95 days (early onset stage), 108 days (middle onset stage) and 122 days (late onset stage). RT-PCR, Western blotting and double immunofluorescence labeled technique were used to detect the expressions of DDX5 and TCF12 in the hippocampus. Co-immunoprecipitation assasy was used to detect the interaction between DDX5 and TCF12.    Results  Compared with the wild-type mice of the same age, DDX5 and TCF12 mRNA in the hippocampus of SOD1-G93A mutant ALS transgenic mice were unchanged, but DDX5 and TCF12 protein were up-regulated significantly at day 95, 108 and 122. DDX5 and TCF12 positive cells were found in both DG area and hippocampus proper, and DDX5 and TCF12 were co-localized with neurons. The immunoreactivities of DDX5 and TCF12 in the hippocampus of SOD1-G93A mutant transgenic mice were elevated compared with wild-type mice at the same time point. Co-immunoprecipitation assasys confirmed that there existed interactions between DDX5 and TCF12 protein.    Conclusion  DDX5 and TCF12 protein are up-regulated in the hippocampal tissues of SOD1-G93A mutant ALS transgenic mice. The abnormal expressions of DDX5 and TCF12 are involved in the hippocampal lesions of ALS.

Key words: Amyotrophic lateral sclerosis, mouse DEAD-box helicase 5, Transcription factor 12, Hippocampus, Co-immunoprecipitation assay, SOD1-G93A transgenic mouse

中图分类号: